Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Oncology Department of Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China.
Front Immunol. 2022 Aug 24;13:952546. doi: 10.3389/fimmu.2022.952546. eCollection 2022.
BACKGROUND: There is a crosstalk between gut microbiota (GM) and cancer immunotherapy (CI). The purpose of this study is to use bibliometric analysis to identify the highly cited papers relating to GM/CI and explore the research status and development trends of the GM/CI research. METHODS: A literature search regarding GM/CI publications from 2012 to 2021 was undertaken on July 4, 2022. The article titles, journals, authors, institutions, countries, total citations, keywords, and other information were extracted from the Science Citation Index Expanded (SCIE) of Web of Science Core Collection (WoSCC). The Bibliometrix of R package and VOSviewer were used for bibliometric analysis. RESULTS: A total of 665 papers were extracted. The number of papers has increased rapidly over the past decade, especially after 2018. The United States and China had the most publications and made great contributions to this field. Th5e Univ Texas MD Anderson Canc Ctr and Univ Paris Saclay were absolutely in the leading position in GM/CI. The most influential authors were Zitvogel L and Routy B. had the most publications and had the most total citations. Historical direct citation analysis explained the historical evolution in GM/CI. Highly cited papers and high-frequency keywords illustrated the current status and trends of GM/CI. Four clusters were identified and the important topics included the role of GM and antibiotics in CI, the methods of targeting GM to improve CI outcomes, the mechanism by which GM affects CI and the application of ICIs in melanoma. "Tumor microbiome", "proton pump inhibitors" and "prognosis" may be the new focus of attention in the next few years. CONCLUSION: This study filtered global publications on GM/CI correlation and analyzed their bibliometric characteristics, identified the most cited papers in GM/CI, and gained insight into the status, hotspots and trends of global GM/CI research, which may inform researchers and practitioners of future directions.
背景:肠道微生物群(GM)和癌症免疫治疗(CI)之间存在串扰。本研究旨在使用文献计量分析确定与 GM/CI 相关的高引用论文,并探讨 GM/CI 研究的研究现状和发展趋势。
方法:于 2022 年 7 月 4 日,在 Web of Science Core Collection(WoSCC)的科学引文索引扩展版(SCIE)上对 2012 年至 2021 年期间 GM/CI 出版物进行文献检索。从文章标题、期刊、作者、机构、国家、总引文、关键词等信息。使用 R 包 Bibliometrix 和 VOSviewer 进行文献计量分析。
结果:共提取了 665 篇论文。在过去十年中,论文数量迅速增加,特别是在 2018 年之后。美国和中国发表的论文最多,为本领域做出了巨大贡献。Th5e Univ Texas MD Anderson Canc Ctr 和 Univ Paris Saclay 在 GM/CI 中处于绝对领先地位。最有影响力的作者是 Zitvogel L 和 Routy B。 发表的论文最多, 总引文最多。历史直接引文分析解释了 GM/CI 的历史演变。高被引论文和高频关键词说明了 GM/CI 的现状和趋势。确定了四个聚类,重要主题包括 GM 和抗生素在 CI 中的作用、靶向 GM 以改善 CI 结果的方法、GM 影响 CI 的机制以及 ICIs 在黑色素瘤中的应用。“肿瘤微生物组”、“质子泵抑制剂”和“预后”可能是未来几年的新关注点。
结论:本研究筛选了全球关于 GM/CI 相关性的出版物,并分析了它们的文献计量特征,确定了 GM/CI 中最具引用价值的论文,深入了解了全球 GM/CI 研究的现状、热点和趋势,为未来的研究人员和实践者提供了方向。
Front Cell Infect Microbiol. 2022
Front Cell Infect Microbiol. 2024
Front Cell Infect Microbiol. 2023
Hum Vaccin Immunother. 2023-8-1
Front Cell Infect Microbiol. 2022
Front Endocrinol (Lausanne). 2022
Medicine (Baltimore). 2025-2-21
Front Microbiol. 2024-11-6
Cell Mol Neurobiol. 2024-6-10
Clin Cosmet Investig Dermatol. 2024-2-9
Medicine (Baltimore). 2023-12-15
Front Med (Lausanne). 2022-5-19
J Hematol Oncol. 2022-4-29
Nat Med. 2022-4
Front Immunol. 2022-3-31